Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ETBusiness Wire · 4 days ago
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-TermZacks Investment Research · 5 days ago
Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research · Oct 14, 2026
Henry Schein Announces Chief Financial Officer Leadership TransitionBusiness Wire · Oct 8, 2026
HSIC or MMSI: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 6, 2026
Should Value Investors Buy Henry Schein (HSIC) Stock?Zacks Investment Research · Oct 6, 2026Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $1.24 | $1.27 | Beat |
| May 5, 2026 | $1.20 | $1.32 | Beat |
| Feb 24, 2026 | $1.30 | $1.34 | Beat |
| Nov 4, 2025 | $1.27 | $1.38 | Beat |
| Aug 5, 2025 | $1.18 | $1.10 | Miss |
| May 5, 2025 | $1.11 | $1.15 | Beat |